Showing of 0 - 10 from 50 results
Novartis - Total results - 50
Sep 06, 2016
Sun Pharma inks distribution alliance with Mitsubishi Tanabe for 14 brandsThese 14 prescription brands acquired by the company earlier this year will be transferred from Novartis Pharma K.K. to Sun Pharma's subsidiary in Japan beginning October 2016
Jun 06, 2016
Prices of cancer, diabetes, blood pressure drugs slashed by 25%Prices of 56 important drugs used in treatment of cancer, diabetes, bacterial infections and blood pressure have been capped by the government thereby reducing the cost by an average of around 25 percent.
Jun 06, 2016
Prices of 56 drugs to come down; NPPA fixes ceiling ratesPrices may come down of 56 important medicines used in treatment of cancer, diabetes, bacterial infections and high blood pressure, with the government fixing their ceiling prices under the drug pricing control mechanism.
Jun 06, 2016
PM invites Swiss business leaders to invest in IndiaSeeking to create two or three Switzerlands within India, Prime Minister Narendra Modi today courted Swiss business leaders to boost domestic manufacturing and skill development.
Dec 31, 2015
Warning letters for pharma cos galore: Now Cadila Healthcare faces USFDA heat, stock tanks 16%The Ahmedabad-headquartered company received a warning letter for its Moraiya formulation facility and Ahmedabad API facility
Nov 17, 2015
India needs predictable IPR regime, says NovartisIf the whole data regulatory process becomes predictable in the long run, it makes investment in the country more sustainable, said Novartis Pharma AG, Global Head of Development, Established Medicines Franchise, Lutz Hegemann.
Feb 10, 2015
Natco Pharma gains 4.5% after filing ANDA with USFDANatco Pharma has filed new product applications with the US health regulator for generic version of drugs used in the treatment of nervous system disease and cancer.
Jan 14, 2015
Delhi HC bars Cipla from selling cheaper copy of Novartis respiratory drugCipla, India's fourth-largest generic drugmaker by revenue, had launched its copy of Onbrez in New Delhi in October last year at a fifth of the original drug's price, citing urgent unmet need in India.
Dec 17, 2014
Novartis sues Cipla for infringing respiratory drug patentSwiss drugmaker Novartis AG said on Wednesday it had sued India's Cipla Ltd for infringing patents covering its respiratory drug Onbrez, a month after Cipla launched a copy at a fifth of the original drug's price.
Nov 23, 2014
Did Tata Memorial Hospital intentionally loot its cancer patients?Tata Memorial Hospital in Mumbai has admitted to overcharging cancer patients for a Novartis-branded oncology medicine over the last nine months,